title: Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy.
authors: Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT.
authors: Jing
authors: J
authors: Hughes
authors: Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
authors: Nalini
authors: N
authors: Vudattu
authors: Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
authors: Mario
authors: M
authors: Sznol
authors: Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
authors: Scott
authors: S
authors: Gettinger
authors: Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
authors: Harriet
authors: H
authors: Kluger
authors: Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT.
authors: Beatrice
authors: B
authors: Lupsa
authors: Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT kevan.herold@yale.edu.
authors: Kevan C
authors: KC
authors: Herold
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D015551:Autoimmunity; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D018450:Disease Progression; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab